RxNorm Semantic Concepts Index - 121
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "121".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 1210 | Adenosine triphosphate (ATP) citrate (pro-3S)-lyase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1210 | Adenosine triphosphate (ATP) citrate (pro-3S)-lyase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1210 | Adenosine triphosphate (ATP) citrate (pro-3S)-lyase | Full form of descriptor (FN) | NO | |
| RxCUI: 1210 | Adenosine triphosphate (ATP) citrate (pro-3S)-lyase | Designated preferred name (PT) | NO | |
| RxCUI: 1210 | Adenosine triphosphate (ATP) citrate (pro-3S)-lyase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 121002 | HLA - Human leukocyte antigen DR103 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 121002 | HLA - Human leukocyte antigen DR103 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 121002 | HLA - Human leukocyte antigen DR103 | British preferred term (PTGB) | NO | |
| RxCUI: 121002 | HLA - Human leukocyte antigen DR103 | Designated preferred name (PT) | NO | |
| RxCUI: 121002 | HLA - Human leukocyte antigen DR103 | Full form of descriptor (FN) | NO | |
| RxCUI: 121011 | Lysosomal enzyme | Designated preferred name (PT) | NO | |
| RxCUI: 121011 | Lysosomal enzyme | Full form of descriptor (FN) | NO | |
| RxCUI: 121013 | Anti-A,B | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 121013 | Anti-A,B | Designated preferred name (PT) | NO | |
| RxCUI: 121013 | Anti-A,B | Full form of descriptor (FN) | NO | |
| RxCUI: 121039 | suxamethonium bromide | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 121044 | Imidazole carboxamide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 121047 | Propionate | Full form of descriptor (FN) | NO | |
| RxCUI: 121047 | Propionate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 121047 | Propionate | Designated preferred name (PT) | NO | |
| RxCUI: 121047 | Propionate | Full form of descriptor (FN) | NO | |
| RxCUI: 121047 | Propionate | Designated preferred name (PT) | NO | |
| RxCUI: 121067 | Bryonin | Designated preferred name (PT) | NO | |
| RxCUI: 121067 | Bryonin | Full form of descriptor (FN) | NO | |
| RxCUI: 121068 | Pronestyl | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 121069 | Dimethoxanate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 121069 | Dimethoxanate | Designated preferred name (PT) | NO | |
| RxCUI: 121069 | Dimethoxanate | Full form of descriptor (FN) | NO | |
| RxCUI: 121070 | Chromic phosphate (32-P) | Designated preferred name (PT) | NO | |
| RxCUI: 121070 | Chromic phosphate (32-P) | Full form of descriptor (FN) | NO | |
| RxCUI: 121070 | Chromic phosphate (32-P) | Designated preferred name (PT) | NO | |
| RxCUI: 121070 | Chromic phosphate (32-P) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 121070 | Chromic phosphate (32-P) | Full form of descriptor (FN) | NO | |
| RxCUI: 121073 | furosemide 50 MG/ML Injectable Solution [Lasix] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 121073 | furosemide 50 MG/ML Injectable Solution [Lasix] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 12108 | 1-methylhistidine | Designated preferred name (PT) | NO | |
| RxCUI: 12108 | 1-methylhistidine | Full form of descriptor (FN) | NO | |
| RxCUI: 12108 | 1-methylhistidine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 121093 | Hb 5(A2), Glu-lys | British preferred term (PTGB) | NO | |
| RxCUI: 121093 | Hb 5(A2), Glu-lys | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 121093 | Hb 5(A2), Glu-lys | Designated preferred name (PT) | NO | |
| RxCUI: 121093 | Hb 5(A2), Glu-lys | Full form of descriptor (FN) | NO | |
| RxCUI: 1211 | Adenosine triphosphate (ATP) phosphoribosyltransferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1211 | Adenosine triphosphate (ATP) phosphoribosyltransferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1211 | Adenosine triphosphate (ATP) phosphoribosyltransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 1211 | Adenosine triphosphate (ATP) phosphoribosyltransferase | Designated preferred name (PT) | NO | |
| RxCUI: 1211 | Adenosine triphosphate (ATP) phosphoribosyltransferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 121118 | Zoledronate | Designated preferred name (PT) | NO | |
| RxCUI: 121118 | Zoledronate | Full form of descriptor (FN) | NO | |
| RxCUI: 121176 | Oteracil potassium | Designated preferred name (PT) | NO | |
| RxCUI: 121176 | Oteracil potassium | Full form of descriptor (FN) | NO | |
| RxCUI: 121191 | rituximab | Full form of descriptor (FN) | YES | |
| RxCUI: 121191 | rituximab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 121191 | rituximab | Designated preferred name (PT) | YES | |
| RxCUI: 121191 | rituximab | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 121191 | rituximab | Full form of descriptor (FN) | YES | |
| RxCUI: 121191 | rituximab | Designated preferred name (PT) | YES | |
| RxCUI: 121243 | voriconazole | Full form of descriptor (FN) | YES | |
| RxCUI: 121243 | voriconazole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 121243 | voriconazole | Designated preferred name (PT) | YES | |
| RxCUI: 121243 | voriconazole | Full form of descriptor (FN) | YES | |
| RxCUI: 121243 | voriconazole | Designated preferred name (PT) | YES | |
| RxCUI: 1214 | Guanosine triphosphate (GTP) pyrophosphokinase | Designated preferred name (PT) | NO | |
| RxCUI: 1214 | Guanosine triphosphate (GTP) pyrophosphokinase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1214 | Guanosine triphosphate (GTP) pyrophosphokinase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1214 | Guanosine triphosphate (GTP) pyrophosphokinase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1214 | Guanosine triphosphate (GTP) pyrophosphokinase | Full form of descriptor (FN) | NO | |
| RxCUI: 1214 | Guanosine triphosphate (GTP) pyrophosphokinase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 12166 | 1-octacosanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1217973 | Methedrone | Designated preferred name (PT) | NO | |
| RxCUI: 1217973 | Methedrone | Full form of descriptor (FN) | NO | |
| RxCUI: 1218 | Atracurium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1218 | Atracurium | Designated preferred name (PT) | YES | |
| RxCUI: 1218 | Atracurium | Full form of descriptor (FN) | YES | |
| RxCUI: 1218 | Atracurium | Designated preferred name (PT) | YES | |
| RxCUI: 1218 | Atracurium | Full form of descriptor (FN) | YES | |
| RxCUI: 1219 | Atracurium besilate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1219 | Atracurium besilate | Full form of descriptor (FN) | YES | |
| RxCUI: 1219 | Atracurium besilate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1219 | Atracurium besilate | Designated preferred name (PT) | YES |